مباشر

AgilentA Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus - simplywall.st Endpoints NewsActing FDA chief isn't interested in permanent role Clinical OMICsPost-Stroke Arm Immobility Improved with Spinal Cord Stimulation Lonza NewsStipple Bio and Lonza Agree to Focus on Advancing Oncology ADC Therapies - Genetic Engineering and Biotechnology News Clinical OMICsInfant Brain Development Sheds Light on Parkinson’s Link with Autism Clinical OMICsAlzheimer’s Genetic Risk Loci: 16 New Candidates Endpoints NewsActing FDA commissioner pledges to prevent political interference in rare disease meeting Endpoints NewsDimension seeks up to $750M for third life sciences fund after string of success Endpoints NewsElevance talks 'practical' AI Endpoints NewsMammalian hair, roof leaks: Novo Nordisk's site in Indiana under FDA scrutiny once again Endpoints NewsMammalian hair, roof leaks: Novo's Catalent site in Indiana under FDA scrutiny once again FierceBiotechAutobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2

BioWorld ٤ يونيو ٢٠٢٦

Regulatory actions for June 4, 2026

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast...

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.